Camille Tumiotto
Overview
Explore the profile of Camille Tumiotto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
211
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hemar V, Bouchet S, Ribeiro E, Prier P, Elleau C, Solas C, et al.
J Antimicrob Chemother
. 2024 Sep;
79(12):3354-3355.
PMID: 39347710
No abstract available.
2.
Simoes M, Hodcroft E, Simmonds P, Albert J, Alidjinou E, Ambert-Balay K, et al.
J Infect Dis
. 2024 Mar;
230(4):e917-e928.
PMID: 38547499
Enterovirus D68 (EV-D68) infections are associated with severe respiratory disease and acute flaccid myelitis (AFM). The European Non-Polio Enterovirus Network (ENPEN) aimed to investigate the epidemiological and genetic characteristics of...
3.
Pfirmann P, Garrigue I, Chauveau B, Rondeau V, Tumiotto C, Weinmann L, et al.
Nephrol Dial Transplant
. 2023 Sep;
39(4):627-636.
PMID: 37667539
Background: While opportunistic infections are a frequent and challenging problem in kidney transplant recipients, their long-term epidemiology remains hardly known. Methods: Opportunistic infections were recorded in 1144 recipients transplanted in...
4.
Guerville F, Vialemaringe M, Cognet C, Duffau P, Lazaro E, Cazanave C, et al.
AIDS
. 2023 Mar;
37(7):1035-1046.
PMID: 36928274
Objective: We aimed to determine the contribution of inflammasome activation in chronic low-grade systemic inflammation observed in patients with HIV (PWH) on long-term suppressive antiretroviral therapy (ART) and to explore...
5.
Nyamankolly E, Bellecave P, Wittkop L, Le Marec F, Duffau P, Lazaro E, et al.
Int J Antimicrob Agents
. 2022 Dec;
61(1):106696.
PMID: 36470511
Objective: To assess the efficacy of raltegravir, etravirine and darunavir/ritonavir (TRIO regimen) in treatment-experienced patients with human immunodeficiency virus-1 (HIV-1) infection by describing the proportion of patients who experienced virological...
6.
Lartigau M, Ouattara E, Tumiotto C, Wodrich H, Busson L, Trimoulet P, et al.
J Clin Virol
. 2022 Mar;
149:105134.
PMID: 35313222
Objective: To describe COVID-19 breakthrough infections in two nursing homes (NHs) sites of active COVID-19 clusters despite optimal vaccination coverage. Methods: A cross-sectional study was conducted in two NHs of...
7.
Alizon S, Selinger C, Sofonea M, Haim-Boukobza S, Giannoli J, Ninove L, et al.
Euro Surveill
. 2022 Feb;
27(6).
PMID: 35144725
BackgroundThe COVID-19 pandemic has led to an unprecedented daily use of RT-PCR tests. These tests are interpreted qualitatively for diagnosis, and the relevance of the test result intensity, i.e. the...
8.
Lapaillerie D, Lelandais B, Mauro E, Lagadec F, Tumiotto C, Miskey C, et al.
Nucleic Acids Res
. 2021 Oct;
49(19):11241-11256.
PMID: 34634812
The stable insertion of the retroviral genome into the host chromosomes requires the association between integration complexes and cellular chromatin via the interaction between retroviral integrase and the nucleosomal target...
9.
Camou F, Tinevez C, Beguet-Yachine M, Bellecave P, Ratiarison D, Tumiotto C, et al.
J Med Virol
. 2021 May;
93(9):5594-5598.
PMID: 33942327
This study aims to assess the efficacy and safety of convalescent plasma therapy (CPT) in COVID-19 critically ill patients with protracted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNAemia. A...
10.
Chaussade H, Tumiotto C, Le Marec F, Leleux O, Lefevre L, Lazaro E, et al.
Open Forum Infect Dis
. 2021 Jan;
7(12):ofaa567.
PMID: 33409332
Background: Ritonavir-boosted darunavir (DRV/r) is a protease inhibitor (PI) indicated for the treatment of naïve and pretreated HIV-infected patients since 2007. Our study aims to describe DRV/r-treated patients experiencing virological...